EUVIMEDEUVIMED entdecken
Crossref

MYCN amplification suppresses PD-L1 and CXCL10 to drive an immunosuppressive microenvironment in neuroblastoma

Jingbo Qiao, Camryn D. Chung, Elizabeth D. Cochran, Dai H. Chung

Oncotarget · 18.11.2026 · 17 (1) · 538-554

DOI: 10.18632/oncotarget.28924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 18.11.2026. Verfasst von Jingbo Qiao und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Qiao, J., Chung, C. D., Cochran, E. D., & Chung, D. H. (2026). MYCN amplification suppresses PD-L1 and CXCL10 to drive an immunosuppressive microenvironment in neuroblastoma. Oncotarget, 17(1), 538-554. https://doi.org/10.18632/oncotarget.28924

Vancouver

Qiao J, Chung CD, Cochran ED, Chung DH. MYCN amplification suppresses PD-L1 and CXCL10 to drive an immunosuppressive microenvironment in neuroblastoma. Oncotarget. 2026;17(1):538-554. doi:10.18632/oncotarget.28924

BibTeX
@article{Qiao2026,
  author = {Qiao, Jingbo and Chung, Camryn D. and Cochran, Elizabeth D. and Chung, Dai H.},
  title = {MYCN amplification suppresses PD-L1 and CXCL10 to drive an immunosuppressive microenvironment in neuroblastoma},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {538--554},
  doi = {10.18632/oncotarget.28924}
}
Kostenlos starten →